Last Posted: Jul 16, 2017
- Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer
E Hahnen et al, JAMA Oncology, July 2017 - Take Action to Lower Your Breast and Ovarian Cancer Risk
- Current condition of genetic medicine for hereditary breast cancer.
Terui-Kohbata Hiroko et al. Molecular and clinical oncology 2017 Jul 7(1) 98-102 - Influence of the Angelina Jolie Announcement and Insurance Reimbursement on Practice Patterns for Hereditary Breast Cancer.
Lee Jihyoun et al. Journal of breast cancer 2017 Jun 20(2) 203-207 - The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy.
MacDonald Karen V et al. European journal of cancer (Oxford, England : 1990) 2016 Jul 6185-93 - Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?
Partridge Ann H et al. Breast cancer research and treatment 2017 Jun - Test gives accurate prognosis for breast cancer patients with 'ultralow' risk
A Sandou, Medical News Today, June 30, 2017 - Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades.
Esserman Laura J et al. JAMA oncology 2017 Jun - Test gives accurate prognosis for breast cancer patients with 'ultralow' risk
A Sandou, Medical News Today, June 30, 2017 - Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
LJ Esserman et al., JAMA Oncology, June 28, 2017 - Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.
Thakur Sunitha B et al. Journal of magnetic resonance imaging : JMRI 2017 Jun - BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.
Pilato Brunella et al. Genes, chromosomes & cancer 2016 Oct 55(10) 803-13 - Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
Grindedal Eli Marie et al. BMC cancer 2017 Jun 17(1) 438 - Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology.
Buzolin Ana Lígia et al. Human genomics 2017 Jun 11(1) 14 - The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
Afghahi Anosheh et al. Current treatment options in oncology 2017 May 18(5) 27 - The Role of Genetic Testing in Patients With Breast Cancer: A Review.
Valencia Olivia M et al. JAMA surgery 2017 Jun 152(6) 589-594
No hay comentarios:
Publicar un comentario